1. oc-Amanitin inhibits in vitro the activity of RNA polymerase II of rat brain nuclei. 2. The toxin does not pas the blood-brain barrier, but when injected intracerebrally is highly toxic for rats, and causes inhibition of RNA polymerase II of isolated brain nuclei. 3. Intracerebral injection of oc-amanitin 6h before training to a passive avoidance task is followed by impaired performance of rats on retesting after 7 days, without affecting performance on retesting immediately after training.
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Studies on the possible role of brain macromolecules in memory acquisition and consolidation have produced evidence suggesting (i) that an increased synthesis of RNA and of protein occurs in some parts of the brain during training, and (ii) that the establishment of 'long-term' memory is impaired by inhibitors of synthesis of RNA and protein (for review see Glassman, 1969) .
The experiments reported below indicate that the establishment of long-term memory in rats is impaired by intracerebrally injected ca-amanitin, a specific inhibitor of nuclear RNA polymerase II (Kedinger, Gniazdowski, Mandel, Gissinger & Chambon, 1970; Jacob, Sajdel & Munro, 1970; Lindell, Weinberg, Morris, Roeder & Rutter, 1970) . It will be shown also that this toxin inhibits in vitro and in vivo the activity of RNA polymerase II of rat brain nuclei, although it does not pass the blood-brain barrier. EXPERIMENTAL Chemicals. o-Amanitin was a generous gift from Professor T. Wieland, Heidelberg, Germany; acetoxycycloheximide was purchased from Sigma Chemical Co., St Louis, Mo., U.S.A.; the chemicals for RNA polymerase assays were from the same sources as described by Novello & Stirpe (1970) .
Animals. Male rats of the Wistar strain weighing 180-210g were used. Intraventricular injections were given as described by Noble, Wurtman & Axelrod (1967) .
Preparation of nuclei and determination of RNA fpolymerase activity. Nuclei were prepared from liver as described by Chauveau, Moul6 & Rouiller (1956) in 2.2M-sucrose containing 10mM-magnesium acetate instead of CaC12. Brain nuclei were isolated as described by Koenig, Lu, Jacobson, Sanghavi & Nayyar (1970) . Purified nuclei were resuspended in 0.25 M-sucrose containing 1 mM-MgCl2.
The activities of RNA polymerase I and II were determined with and without a-amanitin as described by Novello & Stirpe (1970) . DNA was determined by the method of Burton (1956) .
Testing of memory. This was performed with the apparatus described by Jarvik & Kopp (1967) . Rats were put in the smaller, lighted compartment of a two-compartment box, communicating with the larger, darkened part. The animals stepped spontaneously from the lighted compartment into the darkened one, where they received a 350,IA electric foot shock, from which they escaped by returning to the lighted compartment. Jarvik & Kopp (1967) expressed the degree of training as the length of time the rats remained outside the dark compartment on retest. We observed that untrained animals entered the dark compartment very rapidly, and the variability between individual latencies was very small, whereas trained rats waited for a definitely longer time. Therefore, although the latency times on retest were recorded, in expressing results the animals were considered as 'negative' if they entered the dark compartment within 3 min, and 'positive' if they waited for a longer time.
RESULTS
Effect of oce-amanitin, in vitro and in vivo, on the RNA polymerase activity of rat brain nuclei. Nuclei isolated from whole rat brain showed a low activity of RNA polymerase I and a relatively high activity of RNA polymerase II (Table 1) . Addition of ocamanitin to the reaction mixtures inhibited polymerase II at concentrations ( Fig. 1 ) similar to those effective on rat liver nuclei (Stirpe & Fiume, 1967) , and without affecting significantly the activity of polymerase I. The intraperitoneal injection of a-amanitin at the dose of 5,ug/lOg body wt. is not Experimental conditions were as described in Table 1 for the 'Mn2+, high ionic strength' system. lethal for rats (Wieland, 1957) (Table 2 ). This could be due to lack of penetration of the toxin into the brain, which was circumvented by injecting oc-amanitin intraventricularly. When administered in this way oc-amanitin was much more toxic for rats than when given intraperitoneally, with an LD50 of 0.5-0.8,ug/rat (calculated by correcting for mortality due to the operation; Finney, 1964 Table 2 ). The intracerebral administration of oc-amanitin, even at the highest dosage given in these experiments, did not affect RNA polymerase II of liver nuclei, thus confirming that the toxin does not pass the blood-brain barrier. Effect of ac-amanitin on retention of avoidance conditioning. Retention of the avoidance conditioning was used to assess the training capacity of rats. The validity of the test used was ascertained in a preliminary experiment, in which it was confirmed that long-term retention was significantly impaired in rats injected with acetoxycycloheximide immediately after training. The acetoxycycloheximide was given at a much lower dosage than that used for similar experiments in mice (see e.g. Geller, Robustelli, Barondes, Cohen & Jarvik, 1969) . This was because we observed that this inhibitor is much more toxic for rats (LD50 2.7-3.0mg/kg body wt.) than for mice.
Rats trained 6h after intracerebral injection of oc-amanitin, i.e. when the activity of RNA polymerase II was depressed, showed a significant impairment of the response when retested 7 days later (Table 3) , although they performed normally if retested within 15min from training. oc-Amanitin had no significant effect on the task performance if it was injected 48h before or 24h after training ( Table 2 . Effect in vivo of oc-amanitin on the activity of RNA polymera8e8 I and II of rat brain nuclei ao-Amanitin was injected intraventricularly in all experiments except the first one, and was dissolved in 20,u1 of 0.9% NaCl soln.; controls received the same amount of saline given by the same route. RNA polymerase activity was determined as described in Table 1 . Results are means ±s.E.M. of the numbers of experiments given in parentheses.
Expt.
no. Treatment 1
Saline (2) oc-Amanitin (5pg/1Og body wt.) intraperitoneally 6h before death (2) 2 Saline (1) ac-Amanitin (I00,g) 1 h before death (1) 3 Saline (1) oc-Amanitin (100lg) 6h before death (1) 4 Saline (1) oc-Amanitin (10jug) 6h before death (1) 5 Saline (4) oc-Amanitin (0.5,ug) 6h before death (7) ac-Amanitin (0.25vAg) 6h before death (6) 6 Saline (2) ac-Amanitin (0.25,ug) 12h before death (2) 7 Saline (2) ar-Amanitin (0.25,Ig) 24h before death (2) 8 Saline (2) ac-Amanitin (0.25,ug) 48h before death (2) RNA polymerase activity (pmol of AMP incorporated/1Omin per mg of DNA) The intraventricular injection of a-amanitin (0.25,ug/rat) did not cause apparent modifications in the behaviour of the rats, except that 15% of the animals surviving the injection showed aggressive behaviour, which lasted for at least 10 days, when the animals were killed for other purposes. Two of these animals refused food after the injection until their death. Kato & Kurokawa (1970) reported that the RNA polymerase activity of guinea-pig brain nuclei is stimulated by high ionic strength, and to a greater extent than that of rat liver nuclei. Similar results were obtained in our experiments with rat brain nuclei, and the fact that the activity stimulated by Biochem. 1971, 125 high iOlniC strength is inhibited by x-amanitin demonstrates the presence in brain of a high activity of RNA polymerase II (according to the nornenclature of Roeder & Rutter, 1969) . oa-Amanitin seems not to pass the blood-brain barrier, since the brain polymerase is not affected when the toxin is given intraperitoneally, whereas liver polymerase is not inhibited after the intracerebral injections. When given in the latter way, oc-amanitin is much more toxic for rats than when injected intraperitoneally. It is possible that this higher toxicity is due to the impermeability of the blood-brain barrier, which presumably does not allow a rapid elimination of the toxin from the brain.
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DISCUSSION
The injection of sublethal doses of oc-amanitin impairs the establishment of long-term memory in rats. It is tempting to correlate this effect with the inhibition of RNA polymerase II, as is also suggested by the fact that a-amanitin has no effect on memory if the training is given 48h after the poisoning, i.e. after the activity of RNA polymerase is restored. It is not certain, however, that ocamanitin affects only RNA polymerase II. Even assuming that this enzyme is the only direct target of oc-amanitin, the consequences of its inhibition on other reactions are not yet known, and therefore it remains to be ascertained whether the effect of oc-amanitin on memory is due to inhibition of RNA polymerase II itself, or to the possible consequent impairment of other reactions, and especially of protein synthesis. Whatever the exact mechanism, oc-amanitin seems to affect the consolidation of memory from short-to long-term, since the toxin has no effect on the acquisition of short-term memory, nor does it suppress the long-term memory once this is established. These results exclude also an effect on retrieval rather than on fixation of memory, and on the ability to perform the assigned task. Thus it seemis unlikely that the observed effects on long-term memory are a non-specific consequence of the administration of a toxic substance, and it seeins possible that o-amanitin affects memory in a manner similar to other inhibitors of RNA and of protein synthesis.
